Cell death-induced activation of epidermal growth factor receptor in keratinocytes: Implications for restricting epidermal damage in dermatitis

被引:21
作者
Iordanov, MS
Sundholm, AJ
Simpson, EL
Hanifin, JM
Ryabinina, OP
Choi, RJ
Korcheva, VB
Schneider, P
Magun, BE
机构
[1] Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA
[2] Oregon Hlth Sci Univ, Dept Dermatol, Portland, OR 97239 USA
[3] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland
关键词
apoptosis; dermatitis; spongiosis;
D O I
10.1111/j.0022-202X.2005.23804.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Recent findings have implicated Fas/Fas ligand (FasL) in mediating the death of keratinocytes in spongiotic lesions. We asked whether dying keratinocytes could potentially initiate a protective response of the skin to limit the destruction of the epidermis in the spongiotic areas. In addition to apoptosis, treatment of keratinocyte cultures in vitro with FasL triggers a profound phoshorylation of the epidermal growth factor receptor (EGFR) and of its downstream effectors ERK and protein kinase B (PKB/Akt). Using a variety of inhibitors and blocking antibodies, we demonstrated that: (i) apoptosis is required for the generation of the signal(s) leading to the activation of EGFR, ERK, and Akt; (ii) the activation of EGFR, ERK, and Akt by FasL is indeed mediated by its bona fide receptor Fas; (iii) the activation of EGFR is essential for the subsequent activation of ERK and Akt; and (iv) apoptotic keratinocytes secrete soluble EGFR ligands (including amphiregulin) that are processed from membrane-bound proligand forms by metal loproteinase(s). Our findings demonstrate a potential mechanism for the restriction and repair of spongiotic damage in eczemas.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 34 条
[1]  
Al Moustafa AE, 1999, CLIN CANCER RES, V5, P681
[2]   Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin [J].
Angel, P ;
Szabowski, A .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :949-956
[3]   Function and regulation of AP-1 subunits in skin physiology and pathology [J].
Angel, P ;
Szabowski, A ;
Schorpp-Kistner, M .
ONCOGENE, 2001, 20 (19) :2413-2423
[4]   WORTMANNIN IS A POTENT PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR - THE ROLE OF PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE IN NEUTROPHIL RESPONSES [J].
ARCARO, A ;
WYMANN, MP .
BIOCHEMICAL JOURNAL, 1993, 296 :297-301
[5]   TACE is required for the activation of the EGFR by TGF-α in tumors [J].
Borrell-Pagès, M ;
Rojo, F ;
Albanell, J ;
Baselga, J ;
Arribas, J .
EMBO JOURNAL, 2003, 22 (05) :1114-1124
[6]   A HEPARIN SULFATE-REGULATED HUMAN KERATINOCYTE AUTOCRINE FACTOR IS SIMILAR OR IDENTICAL TO AMPHIREGULIN [J].
COOK, PW ;
MATTOX, PA ;
KEEBLE, WW ;
PITTELKOW, MR ;
PLOWMAN, GD ;
SHOYAB, M ;
ADELMAN, JP ;
SHIPLEY, GD .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (05) :2547-2557
[7]   Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632
[8]   THE PROTEIN-KINASE ENCODED BY THE AKT PROTOONCOGENE IS A TARGET OF THE PDGF-ACTIVATED PHOSPHATIDYLINOSITOL 3-KINASE [J].
FRANKE, TF ;
YANG, SI ;
CHAN, TO ;
DATTA, K ;
KAZLAUSKAS, A ;
MORRISON, DK ;
KAPLAN, DR ;
TSICHLIS, PN .
CELL, 1995, 81 (05) :727-736
[9]   Inhibition of human caspases by peptide-based and macromolecular inhibitors [J].
Garcia-Calvo, M ;
Peterson, EP ;
Leiting, B ;
Ruel, R ;
Nicholson, DW ;
Thornberry, NA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32608-32613
[10]  
GERDES J, 1991, AM J PATHOL, V138, P867